Proactive osteoporosis care: Lifting for my sixties, seventies, eighties!

A science-backed review and practical guide

Short version: fractures—especially hip fractures—are linked to substantially increased short- and long-term mortality, so early, proactive bone health assessment and conservative management matter. In Peter Attia's book Outlive he says "up to one third of people over 65 who fracture their hip are dead within one year." I generally recommend earlier DXA screening for at-risk women (and individualized follow-up), plus targeted lifestyle measures (nutrition, supplements when needed, strength/impact exercise, balance work) to reduce fracture risk and preserve function. Below I review the evidence you asked about, summarize practical monitoring (including DXA timing), and give clear, evidence-based supplement and exercise recommendations you can use with patients.

What the literature shows (brief review of the supplied articles and related guidelines)

1. Diagnostics & treatment update (recent guideline review)

A current review of osteoporosis diagnostics and therapeutics summarizes modern approaches to screening, diagnosis, and conservative care (bone mineral density testing, fracture risk estimation, nonpharmacologic strategies, and pharmacologic options when indicated). It emphasizes individual risk assessment and tailoring monitoring and treatment to fracture risk and comorbidity. PubMed

2. Fracture → increased mortality

Large observational studies consistently demonstrate that hip and other major osteoporotic fractures are followed by an increased risk of death compared with age-matched peers; the excess mortality is greatest in the first year after hip fracture but persists for years afterward. This relationship underlines why fracture prevention is not cosmetic: it’s life-preserving. PMC+1

3. Why earlier, proactive DXA can be justified

Population screening guidance (USPSTF and other bodies) generally recommends DXA screening for women ≥65 years and for younger postmenopausal women with risk factors (smoking, low BMI, prior fracture, glucocorticoid use, parental hip fracture, heavy alcohol use, secondary causes of osteoporosis) because that’s where the balance of benefit and harm is clearest. However, clinical practice guidelines and reviews (and my own clinical experience) support earlier DXA in people with risk factors or accelerated bone loss—because detecting low bone mass sooner allows conservative measures (nutrition, exercise, fall prevention, and, when warranted, pharmacologic therapy) to be started before a fracture occurs. Put simply: being proactive can change trajectory. USPSTF+1

Practical DXA (bone densitometry) approach — what I recommend and why

• Standard guideline: routine DXA for women ≥65 and for younger postmenopausal women with one or more risk factors. This is the USPSTF/major-society default. USPSTF

• My proactive stance: for patients with risk factors (low BMI <20–22, long steroid courses, early menopause, prior fragility fracture, significant family history, malabsorption, heavy alcohol use, inflammatory disease, or rapid weight loss), I recommend considering DXA earlier — often in the mid-50s or earlier when risk signals are present — so we can intervene conservatively before fracture. This is clinician judgment informed by guidelines and by evidence that fracture carries real mortality and morbidity risk. PMC+1

• Repeat DXA timing: for low risk / stable patients, repeating DXA every 2–5 years is common; for patients on bone therapy or with recent rapid loss, earlier re-testing at ~12–24 months may be appropriate to document response. Follow guideline recommendations and individualize frequency. PubMed

Conservative (non-drug) strategies shown to reduce fracture risk or improve resilience

1. Nutrition & supplements

   • Vitamin D

     • Many guideline panels recommend meeting the RDA (600 IU = 15 μg for most adults <70; 800 IU = 20 μg for adults >70). Clinical practice often uses 1,000–2,000 IU/day (25–50 μg/day) when sun exposure or dietary intake is low; this is within commonly used safe ranges and frequently used to maintain 25-OH-D in the target range. Routine high-dose bolus therapy is generally not preferred for fracture prevention. Test 25-OH-D when clinically indicated (malabsorption, obesity, prior deficiency) and adjust dosing to achieve target levels. Endocrine Society+1

       • Examples: Vitamin D3 1,000 IU/day (25 μg) or 2,000 IU/day (50 μg) are commonly used. (1 IU cholecalciferol = 0.025 μg → 1,000 IU = 25 μg; 2,000 IU = 50 μg.)

   • Vitamin C

     • Vitamin C supports collagen synthesis and may help bone matrix health indirectly. Food sources (citrus, bell peppers, strawberries, kiwi) are the primary recommendation; supplemental vitamin C is acceptable when intake is low. Typical supplemental ranges studied for systemic benefits are ~200–500 mg/day; some trials examined 500 mg–2 g/day for endothelial or antioxidant outcomes, but usual dietary targets are much lower (RDA ~75 mg for adult women). I commonly recommend aiming for dietary vitamin C (≈75–200 mg/day) and using supplements (e.g., 250–500 mg/day) when dietary intake is poor. Office of Dietary Supplements+1

   • Calcium (brief note)

     • Aim to meet dietary calcium (1,000 mg/day for most adult women; 1,200 mg/day for women >50) primarily via food. Use supplements only to fill gaps; avoid routinely exceeding total intakes of ~1,200–1,500 mg/day without a clear clinical rationale. (See specific guidelines for calcium use and interactions with certain medications.) PubMed

   Food examples (good sources):

   • Vitamin D food sources: fatty fish (salmon 3.5 oz ≈ 300–1000 IU depending on type; e.g., wild salmon often ~400–700 IU), fortified milk (≈100 IU per cup), fortified plant milks and cereals. Sunlight exposure also generates vitamin D (varies by latitude/skin tone/season). When diet + sun are insufficient, supplements are reasonable. PubMed

   • Vitamin C food sources: orange (≈70 mg per medium orange), 1 cup raw red bell pepper (≈190 mg), 1 cup strawberries (≈85 mg), kiwi (≈70 mg). Eating a variety of fruits and vegetables usually meets vitamin C needs. Healthline+1

   Bottom line on supplements: it’s OK to use supplements when diet or labs show insufficiency. For vitamin D, I commonly recommend 1,000–2,000 IU/day when needed and tailor to 25-OH-D results; for vitamin C, emphasize food first and consider 250–500 mg/day supplemental when intake is inadequate.

2. Exercise — the most impactful conservative strategyA multicomponent exercise program is best for bone and fall prevention: resistance training + impact/weight-bearing + balance/functional training. Evidence shows resistance and impact activities increase/maintain bone mineral density and reduce fall risk when done consistently. Recommended elements include:

   • Resistance training: 2–3 sessions/week focusing on major muscle groups (squats, deadlifts, lunges, rows, chest press) progressing load over time. Heavy-load strength training (within tolerance and safe technique) stimulates bone. PMC

   • Impact/weight-bearing: jumps, hops, brisk walking, stair climbing, or uphill walking—dosage depends on fitness and joint status. For those who cannot tolerate high impact, progressive lower-impact loading (fast walking, step-ups) still helps. PMC

   • Balance & fall-prevention: Tai Chi, single-leg stands, dynamic balance drills, and functional mobility training reduce falls and are safe for many older adults. I am a huge advocate for daily toe yoga - this helps with foot strength, balance, and grounding. These are critical because most hip fractures happen after a fall. PMC+1

3. Lifestyle & risk reduction

   • Smoking cessation, limiting high-risk alcohol intake, optimizing vision and footwear, home safety modifications (remove trip hazards, adequate lighting, grab bars as needed), and medication reviews (to reduce sedative/hypotensive meds that increase fall risk) are all important, evidence-based measures.

4. When to consider pharmacologic therapy

   • If DXA T-score ≤ −2.5 (osteoporosis), prior low-trauma hip or vertebral fracture, or high fracture probability by FRAX, pharmacologic therapy (bisphosphonates, denosumab, anabolic agents as indicated) should be discussed. The decision is individualized, balancing fracture risk, comorbidity, and patient preferences. Guidelines and the diagnostics/treatment review provide algorithms for this. PubMed

Quick, patient-friendly action plan (for busy clinicians or patients)

1. Assess fracture risk: age, prior fracture, family history, glucocorticoids, smoking, alcohol, BMI, secondary causes. If any risk factor → consider earlier DXA. (USPSTF: screen ≥65 or younger with risk factors.) USPSTF

2. Consider baseline labs as indicated: calcium, 25-OH-vitamin D, TSH, and tests for secondary causes when clinically suggested. Treat deficiencies (vitamin D) before or alongside therapy. PubMed

3. Start conservative measures today: dietary counseling (calcium + vitamin D + vitamin C rich foods), prescribe appropriate vitamin D (e.g., 1,000–2,000 IU/day when needed), begin progressive resistance training and balance exercises, and implement fall-prevention strategies. Endocrine Society+1

4. Follow-up & monitoring: repeat DXA per risk (often 1–3 years if high risk or on therapy, 2–5 years if low risk). Recheck 25-OH-D if dosing or malabsorption concerns. PubMed

Specific supplement examples (practical dosing, with conversions)

• Vitamin D3:

  • Common clinician doses: 1,000 IU/day (25 μg) or 2,000 IU/day (50 μg).

    • Why: these doses are within commonly recommended ranges to maintain serum 25-OH-D without routinely needing high-dose boluses. Convert: 1,000 IU = 25 μg; 2,000 IU = 50 μg. Adjust to labs/clinical context. Endocrine Society+1

• Vitamin C:

  • Diet target: aim for 75 mg/day minimum (RDA for adult women) and ideally 100–200 mg/day from food.

  • Supplement option: 250–500 mg/day when dietary intake is low. Higher supplemental doses (≥500 mg/day) appear in some trials for antioxidant/endothelial effects but are not required for routine bone health. Avoid megadoses chronically unless clinically justified. Office of Dietary Supplements+1

• Calcium: aim for dietary calcium 1,000 mg/day (women <50) and ~1,200 mg/day (women ≥50). Use supplements only to reach total target; avoid chronically exceeding ~1,200–1,500 mg total daily calcium without clear indication. PubMed

Why this matters: the mortality link and the clinical imperative

Because hip and major fragility fractures are associated with notable excess mortality and functional decline, preventing the first fracture is a high-value clinical goal—especially in midlife women approaching or in menopause. Conservative strategies (nutrition, vitamin D repletion, resistance + impact + balance exercise, and fall prevention) are low-risk, scalable, and evidence-based means to reduce fracture risk and preserve independence. PMC+2BioMed Central+2

Final clinician note (my practice tip)

I routinely emphasize proactive screening and early lifestyle intervention. For many patients I discuss an individualized plan: earlier DXA when risk factors exist, vitamin D supplementation when diet or sun exposure is inadequate (typical starting dose 1,000–2,000 IU/day with adjustment by lab), clear resistance-and-balance exercise prescription (2–3 strength sessions + 2 balance/impact sessions per week as tolerated), and fall-risk mitigation. These steps are pragmatic, low-risk, and often change a patient’s fracture trajectory—potentially reducing not only fractures but the downstream morbidity and mortality that too often follows them.